DARE Dare Bioscience, Inc. - Common Stock
$0,81
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 13, 2026
Zakres 52 tyg.
$1–$4
2% of range
Ocena Analityków
BUY
9 analysts
Cena Docelowa
$10
+1097% upside
P/E (TTM)
-0.7
ROE
270.9%
Marża Zysku Netto
-1300.7%
DARE Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.81
Kapitalizacja Rynkowa
$12M
P/E (TTM)
-0.7
EPS (TTM)
$-1.20
Przychody (TTM)
$1M
Stopa dywidendy
—
ROE
270.9%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$1 – $4
DARE Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$1M
2016-12-31
→
2025-12-31
EPS
$-1.20
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-10M
2016-12-31
→
2025-12-31
Marże
-1300.7%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
DARE
Mediana porównawcza
P/E (TTM)
-0.7
53.4
P/S (TTM)
11.4
17.7
P/B
4.1
4.8
Price / FCF (Cena / FCF)
-1.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
DARE
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-1315.5%
—
Net Profit Margin (Marża Zysku Netto)
-1300.7%
-280.9%
ROA
-49.1%
-28.2%
ROE
270.9%
-50.7%
ROIC
-476.8%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
DARE
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
1.1
1.7
Quick Ratio (Wskaźnik Szybkości)
1.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
DARE
Mediana porównawcza
Revenue YoY (Przychody R/R)
10429.4%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-53.1%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
DARE
Mediana porównawcza
DARE Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
9 analityków
- Mocne kupno 2 22,2%
- Kup 6 66,7%
- Trzymaj 1 11,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
3 analityków · 2026-08-15
Mediana
$9.00
Średnia
$9.67
← Poniżej wszystkich celów
$0.81
Niski
$8.00
Wysoki
$12.00
Średni cel
$9.00
+1014,3%
Średnia cel
$9.67
+1096,8%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.12%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.20 | $-0.30 | 0.10% |
| 31 grudnia 2025 | $-0.02 | $-0.44 | 0.42% |
| 30 września 2025 | $-0.28 | $-0.36 | 0.08% |
| 30 czerwca 2025 | $-0.45 | $-0.59 | 0.14% |
| 31 marca 2025 | $-0.50 | $-0.59 | 0.09% |
| 31 grudnia 2024 | $-0.65 | $-0.54 | -0.11% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| BFRI | — | — | — | — | — | — |
| COCP | $14M | -1.3 | — | — | -151.4% | — |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| TRAW | — | 1.4 | 1134.5% | — | — | — |
| ADIL | $244.4K | -0.0 | — | — | -146.8% | — |
| CNSP | — | -0.1 | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Cost of Revenue | $295.8K | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $14M | $22M | $30M | $31M | $21M | $9M | $6M | $984.7K | $72.7K | $26M | $12M | |
| SG&A Expense | $9M | $9M | $12M | $11M | $8M | $7M | $5M | $5M | $3M | $157.9K | $11M | $9M | |
| Operating Expenses | $14M | $23M | $34M | $41M | $39M | $27M | $14M | $17M | $11M | $630.6K | $37M | $20M | |
| Operating Income | $-14M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | $-11M | $-630.6K | · | · | |
| Interest Expense | · | · | · | · | · | · | · | · | $322.6K | $42.1K | $2M | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $86.0K | $10.0K | $9.0K | |
| Other Non-op | $-153.1K | $981.5K | $778.5K | $437.8K | $2.5K | $1.5K | $81.0K | $143.5K | $-322.6K | $-2M | $-2M | $-3M | |
| Pretax Income | $-14M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-673.0K | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.2K | $0 | · | · | · | |
| Net Income | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| EPS (Basic) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| Shares (Basic) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| Shares (Diluted) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| EBITDA | $-12M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | · | $261.0K | $192.0K | $126.0K |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $16M | $10M | $35M | $52M | $5M | $5M | $7M | $8M | $44.6K | $219.4K | $51M | |
| Receivables | · | · | · | · | $0 | · | · | · | · | $823.0K | · | · | |
| Prepaid Expense | $387.1K | $3M | $6M | $7M | $2M | $2M | $1M | $403.1K | $311.6K | $1M | · | · | |
| Other Current Assets | $573.1K | $0 | $0 | $0 | · | · | · | $0 | $193.5K | · | · | · | |
| Current Assets | $27M | $18M | $18M | $43M | $55M | $7M | $6M | $7M | $8M | $44.6K | $77M | $53M | |
| PP&E (Net) | $2M | $1M | $656.0K | $64.9K | $26.0K | $37.9K | $63.5K | $9.4K | $0 | $668.0K | $576.0K | $342.0K | |
| PP&E (Gross) | $2M | $2M | $801.7K | · | · | · | · | · | · | $2M | $2M | $2M | |
| Accum. Depreciation | $338.0K | $175.9K | $145.7K | · | · | · | · | · | · | $1M | $1M | $1M | |
| Goodwill | · | · | · | · | · | · | · | $0 | $5M | · | · | · | |
| Other Non-current Assets | $1M | $1M | $599.6K | $254.3K | $485.1K | $528.9K | $935.3K | $578.0K | $723.2K | $12.7K | $347.0K | $215.0K | |
| Total Assets | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Accounts Payable | $1M | $1M | $3M | $2M | $2M | $1M | $1M | $459.7K | $308.2K | $12.7K | $2M | $1M | |
| Accrued Liabilities | $725.2K | $3M | $3M | $11M | $3M | $3M | $2M | $631.4K | $658.4K | $5M | $6M | $4M | |
| Short-term Debt | · | · | · | · | $0 | $367.3K | $0 | · | · | · | · | · | |
| Current Liabilities | $24M | $22M | $20M | $32M | $16M | $8M | $6M | $1M | $966.7K | $755.2K | $16M | $8M | |
| Capital Leases | $559.4K | $754.4K | $935.7K | $90.3K | $0 | $41.8K | $389.6K | $389.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $41.8K | $389.6K | $9.7K | · | $1M | $473.0K | $7.0K | |
| Total Liabilities | $30M | $28M | $26M | $33M | $17M | $9M | $7M | $1M | $967.0K | $755.2K | · | · | |
| Total Debt | · | · | · | · | $0 | $367.3K | · | · | · | · | · | · | |
| Common Stock | $1.4K | $870 | $833 | $8.5K | $8.4K | $4.2K | $2.0K | $1.1K | $605 | $91 | $3.0K | $2.0K | |
| Paid-in Capital | $192M | · | · | · | · | · | · | · | · | · | · | $167M | |
| Retained Earnings | $-189M | $-175M | $-171M | $-141M | $-110M | $-71M | $-44M | $-29M | $-12M | $-727.8K | $-161M | $-122M | |
| AOCI | $-421.6K | $-428.8K | $-360.9K | $-351.3K | $-155.0K | $-91.4K | $-102.6K | $-96.7K | $-18.1K | · | · | · | |
| Stockholders' Equity | $3M | $-6M | $-5M | $11M | $39M | $-1M | $440.8K | $7M | $13M | $-710.6K | $-46.9K | $45M | |
| Liabilities + Equity | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Shares Outstanding | 14,499,502 | 8,700,386 | 8,331,161 | 7,068,790 | 83,944,119 | 41,596,253 | 19,683,401 | 11,422,161 | 6,047,161 | 910,000 | 27,346,780 | 20,125,049 |
Przepływy pieniężne 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $42.3K | · | · | · | · | · | · | · | $261.0K | $192.0K | $126.0K | |
| Stock-based Comp | $1M | $2M | $3M | $2M | $2M | $742.0K | $462.2K | $139.3K | $15.8K | $9.0K | $2M | $885.0K | |
| Other Non-cash | $382.4K | · | · | · | · | · | · | · | · | $3M | $5M | $3M | |
| Operating Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | $-3M | $-372.3K | $-32M | $-19M | |
| CapEx | $385.3K | $573.0K | $629.4K | $63.1K | $14.5K | $17.6K | $0 | $11.8K | $0 | $535.0K | $277.0K | $225.0K | |
| Investing Cash Flow | $-385.3K | $-573.0K | $-629.4K | $-63.1K | $-14.5K | $-17.6K | $6M | $-518.8K | $10M | · | · | · | |
| Stock Issued | $21M | $453.6K | · | $1M | $16M | $23M | $5M | · | · | $918.0K | $3M | $140.0K | |
| Net Stock Activity | $21M | · | · | $1M | $16M | $23M | · | · | · | $918.0K | $3M | $140.0K | |
| Financing Cash Flow | $19M | $354.5K | $16M | $1M | $76M | $25M | $5M | $10M | $155.0K | · | · | · | |
| Net Change in Cash | $9M | $5M | $-24M | $-17M | $47M | $-110.6K | $-2M | $-754.0K | $8M | $-174.8K | $25M | $46M | |
| Free Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | · | $-34M | $-32M | $-19M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1315.5% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | · | · | · | |
| Net Margin | -1300.7% | -41430.9% | -1074.2% | -309.5% | · | · | · | · | · | -5131.2% | · | -29177.5% | |
| Pretax Margin | -1314.4% | -41414.6% | -1074.1% | -309.5% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1156.9% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | 34.1% | · | 157.5% | |
| ROA | -49.1% | -18.7% | -92.7% | -62.1% | -122.2% | -365.5% | -186.8% | -151.6% | · | -67.8% | -60.2% | -77.5% | |
| ROE | 270.9% | 108.1% | 822.2% | -165.2% | -109.5% | 2159.6% | -1267.4% | -205.3% | · | -601.7% | -84.2% | 95.3% | |
| ROIC | -476.8% | 390.1% | 613.0% | -282.4% | -100.8% | 3493.2% | -3254.1% | -251.0% | · | · | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 | 0.9 | 1.1 | 6.6 | · | 2.2 | 4.7 | 6.6 | |
| Quick Ratio | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 | 0.6 | 0.9 | 6.2 | · | 2.1 | 4.6 | 6.3 | |
| Debt / Equity | · | · | · | · | 0.0 | -0.3 | · | · | · | · | · | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.2 | · | · | · | · | · | 0.0 | · | 0.0 |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10429.4% | -99.7% | -71.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -53.1% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Net Income TTM | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| Market Cap | $28M | $27M | $371M | $845M | $2.01B | $669M | $194M | $97M | · | $2.46B | $9.19B | $15.02B | |
| Enterprise Value | · | · | · | · | $1.96B | $665M | · | · | · | · | · | · | |
| P/E | -1.6 | -6.5 | -0.9 | -26.9 | -38.1 | -17.7 | · | · | · | · | · | · | |
| P/S | 27.2 | 2774.4 | 132.0 | 84.5 | · | · | · | · | · | 3209.5 | · | 187766.7 | |
| P/B | 9.8 | -4.5 | -73.4 | 76.0 | 52.0 | -580.7 | 439.4 | 14.5 | · | 187.5 | 188.5 | 331.4 | |
| P / Tangible Book | 9.8 | · | · | 76.0 | 52.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | 5.0 | -9.5 | -46.7 | -70.0 | -26.5 | -14.5 | -9.5 | · | -73.3 | -287.9 | -788.1 | |
| P / FCF | -2.7 | 5.6 | -9.4 | -46.5 | -70.0 | -26.5 | -14.5 | -9.5 | · | -72.2 | -285.4 | -778.9 | |
| EV / EBITDA | · | · | · | · | -50.2 | -24.3 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | -68.2 | -26.3 | · | · | · | · | · | · | |
| Earnings Yield | -62.2% | -15.4% | -111.9% | -3.7% | -2.6% | -5.7% | · | · | · | · | · | · |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $187.5K | $152.5K | $1M | $2.3K | $-21.2K | $25.4K | $-63.6K | $41.7K | $22.4K | $9.3K | $2M | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $319.9K | $242.3K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $242.0K | $660.5K | $622.0K | $1M | $1M | $2M | $3M | $3M | $5M | $3M | $4M | $7M | $6M | $5M | $13M | $4M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $3M | $3M | $2M | $4M | $4M | $5M | $5M | $5M | $7M | $6M | $7M | $9M | $9M | $8M | $16M | $7M | |
| Operating Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-5M | $-5M | $-5M | $-7M | $-6M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| Other Non-op | $-14.8K | $-991 | $-276.6K | $109.4K | $-188.7K | $202.8K | $2M | $-21.2K | $-109.3K | $-732.9K | $113.9K | $97.3K | $227.1K | $340.1K | $287.3K | $119.0K | |
| Net Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-4M | $-6M | $-5M | $13M | $-7M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| EPS (Basic) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.65 | $-0.55 | $1.53 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| EPS (Diluted) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.64 | $-0.55 | $1.52 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| Shares (Basic) | 14,889,832 | 14,522,835 | -19,206,568 | 12,755,112 | 8,871,155 | 8,759,053 | -16,824,405 | 8,534,433 | 8,411,242 | 8,376,189 | -93,030,129 | 7,587,637 | 7,200,260 | 85,517,540 | -168,877,595 | 84,822,516 | |
| Shares (Diluted) | 14,889,832 | 14,522,835 | -19,206,568 | 12,755,112 | 8,871,155 | 8,759,053 | -16,889,394 | 8,534,433 | 8,476,231 | 8,376,189 | -93,030,129 | 7,587,637 | 7,200,260 | 85,517,540 | -169,564,254 | 84,822,516 | |
| EBITDA | $-3M | $-2M | · | $-4M | $-4M | $-4M | · | $-5M | $-7M | $-6M | · | $-8M | $-9M | $-8M | · | $-7M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $19M | $25M | $23M | $5M | $10M | $16M | $11M | $16M | $4M | $10M | $14M | $13M | $20M | $35M | $40M | |
| Prepaid Expense | $835.4K | $680.8K | $2M | $2M | $1M | $1M | $3M | $3M | $4M | $5M | $6M | $7M | $8M | $7M | $7M | $7M | |
| Other Current Assets | $456.4K | $687.8K | · | $53.2K | · | · | · | · | · | $152.2K | · | $831.4K | $272.1K | $201.4K | · | · | |
| Current Assets | $17M | $22M | $27M | $25M | $7M | $12M | $18M | $15M | $21M | $10M | $18M | $22M | $22M | $30M | $43M | $50M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $706.3K | $322.3K | $52.5K | $656.0K | $58.6K | $45.8K | $55.4K | $64.9K | $72.8K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $801.7K | · | · | · | · | · | |
| Accum. Depreciation | · | · | $338.0K | · | · | · | $175.9K | · | · | · | $145.7K | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $533.9K | $528.6K | $654.5K | $599.6K | $796.4K | $920.9K | $799.3K | $254.3K | $736.5K | |
| Total Assets | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Accounts Payable | $762.9K | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $4M | $3M | $5M | $7M | $3M | $2M | $3M | |
| Accrued Liabilities | $448.9K | $529.3K | $725.2K | $2M | $3M | $2M | $3M | $2M | $1M | $1M | $3M | $5M | $4M | $5M | $11M | $4M | |
| Current Liabilities | $17M | $21M | $24M | $21M | $19M | $21M | $22M | $13M | $15M | $18M | $20M | $26M | $25M | $24M | $32M | $23M | |
| Capital Leases | $273.9K | $418.3K | $559.4K | $288.6K | $448.2K | $603.3K | $754.4K | $897.8K | $1M | $1M | $935.7K | $0 | $23.3K | $57.1K | $90.3K | $194.6K | |
| Total Liabilities | $23M | $27M | $30M | $28M | $26M | $28M | $28M | $20M | $21M | $24M | $26M | $27M | $26M | $25M | $33M | $24M | |
| Total Debt | · | · | · | $10.5K | $188.0K | $91.9K | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.5K | $1.5K | $1.4K | $1.4K | $903 | $885 | $870 | $854 | $854 | $10.1K | $833 | $9.8K | $8.7K | $8.6K | $8.5K | $8.5K | |
| Paid-in Capital | $194M | $193M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-195M | $-192M | $-189M | $-187M | $-184M | $-180M | $-175M | $-170M | $-165M | $-178M | $-171M | $-166M | $-158M | $-149M | $-141M | $-125M | |
| AOCI | $-374.9K | $-377.1K | $-421.6K | $-396.0K | $-402.8K | $-415.7K | $-428.8K | $-362.6K | $-385.6K | $-400.1K | $-360.9K | $-419.5K | $-404.5K | $-373.3K | $-351.3K | $-530.7K | |
| Stockholders' Equity | $-560.1K | $734.5K | $3M | $3M | $-13M | $-10M | $-6M | $-1M | $3M | $-11M | $-5M | $-2M | $-3M | $5M | $11M | $26M | |
| Liabilities + Equity | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Shares Outstanding | 15,169,502 | 14,559,502 | 14,499,502 | 13,929,502 | 9,030,386 | 8,850,386 | 8,700,386 | 8,546,364 | 8,546,361 | 100,581,900 | 8,331,161 | 98,292,344 | 86,633,588 | 86,178,996 | 84,825,481 | 83,944,119 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $572.1K | $554.6K | $534.4K | $481.9K | $460.1K | $175.6K | $6.4K | $9.7K | $15.4K | $10.8K | · | · | · | · | · | · | |
| Stock-based Comp | $286.6K | $455.1K | $357.2K | $403.0K | $359.0K | $377.4K | $489.3K | $523.6K | $562.7K | $627.7K | $619.8K | $636.1K | $650.2K | $624.6K | $532.1K | $556.4K | |
| Other Non-cash | · | $-4M | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-6M | $1M | $-442.1K | $-5M | $-5M | $5M | $-6M | $13M | $-7M | $-8M | $-8M | $-7M | $-16M | $-6M | $9M | |
| CapEx | $80.6K | $0 | $206.6K | $174.7K | $-153.4K | $157.3K | $562.8K | $-282.3K | $285.2K | $7.3K | $607.3K | $22.1K | $0 | $0 | $2.7K | $55.0K | |
| Investing Cash Flow | $-80.6K | $0 | $-206.6K | $-174.7K | $153.4K | $-157.3K | $-562.8K | $282.3K | $-285.2K | $-7.3K | $-607.3K | $-22.1K | $0 | $0 | $-2.7K | $-55.0K | |
| Stock Issued | $166.7K | $94.9K | · | · | $475.0K | $436.2K | · | · | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | · | $94.9K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $951.2K | $-715.5K | $424.1K | $19M | $-43.8K | $246.6K | $-211.3K | $436.4K | $115.4K | $14.0K | $5M | $9M | $452.2K | $1M | $-1 | $4.5K | |
| Net Change in Cash | $-6M | $-6M | $2M | $18M | $-5M | $-5M | $4M | $-5M | $13M | $-7M | $-3M | $565.3K | $-6M | $-15M | $-6M | $8M | |
| Free Cash Flow | · | $-6M | · | · | · | $-6M | · | · | · | $-7M | · | · | · | $-16M | · | · |
Rentowność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1582.5% | -1967.1% | · | -162340.8% | · | -18016.8% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| Net Margin | -1590.4% | -1967.7% | · | -157505.1% | · | -17219.1% | · | -11279.4% | 57539.3% | -72622.6% | · | -829.9% | · | · | · | · | |
| EBITDA Margin | -1582.5% | -1603.3% | · | -162340.8% | · | -17394.9% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| ROA | -16.9% | -12.9% | · | -14.6% | -22.0% | -27.7% | · | -21.8% | 55.1% | -31.1% | · | -22.0% | -23.5% | -20.2% | · | -14.1% | |
| ROE | 44.9% | 68.0% | · | -518.8% | 79.8% | 42.6% | · | 249.3% | -53911.2% | 224.1% | · | -69.0% | -57.8% | -44.9% | · | -24.1% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.0 | · | 1.2 | 0.3 | 0.6 | · | 1.1 | 1.4 | 0.6 | · | 0.9 | 0.9 | 1.2 | · | 2.2 | |
| Quick Ratio | 0.7 | 0.9 | · | 1.1 | 0.3 | 0.5 | · | 0.9 | 1.1 | 0.2 | · | 0.5 | 0.5 | 0.8 | · | 1.8 | |
| Debt / Equity | · | · | · | 0.0 | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · |
Efektywność 1
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $98.9K | $98.9K | · | $1M | $1M | $1M | · | $1M | $10M | · | · | · | |
| Net Income TTM | $-14M | $-15M | · | $-17M | $-186.6K | $-3M | · | $-7M | $-11M | $-32M | · | $-32M | $-23M | $-23M | · | $-28M | |
| Market Cap | $32M | $26M | · | $29M | $22M | $26M | · | $28M | $34M | $591M | · | $545M | $946M | $1.08B | · | $1.01B | |
| Enterprise Value | · | · | · | $6M | $17M | $15M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.9 | -1.3 | · | -1.2 | 119.5 | -8.5 | · | -3.5 | -2.5 | -1.8 | · | -2.2 | -7.9 | -46.2 | · | -33.3 | |
| P/S | · | · | · | · | 218.3 | 258.7 | · | 25.8 | 33.4 | 586.0 | · | 544.9 | 94.6 | · | · | · | |
| P/B | -57.1 | 36.1 | · | 10.2 | -1.7 | -2.7 | · | -18.7 | 12.9 | -53.8 | · | -238.1 | -347.9 | 216.3 | · | 38.2 | |
| P / Tangible Book | · | 36.1 | · | 10.2 | · | · | · | · | 12.9 | · | · | · | · | 216.3 | · | 38.2 | |
| P / Cash Flow | · | -4.8 | · | · | · | -4.7 | · | · | · | -86.8 | · | · | · | -66.7 | · | · | |
| P / FCF | · | -4.8 | · | · | · | -4.5 | · | · | · | -86.7 | · | · | · | -66.7 | · | · | |
| EV / EBITDA | · | · | · | -1.7 | -4.4 | -3.5 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -2.7 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | 169.3 | 155.2 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -54.0% | -79.1% | · | -84.8% | 0.84% | -11.8% | · | -28.7% | -39.7% | -54.6% | · | -44.7% | -12.7% | -2.2% | · | -3.0% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $1M | $9.8K | $3M | $10M | $0 |
| Marża Operacyjna % | -1315.5% | -239692.2% | -1101.9% | -313.9% | — |
| Zysk netto | $-13M | $-4M | $-30M | $-31M | $-39M |
| Rozwodniony EPS | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | — | — | 0.0 |
| Wskaźnik bieżący | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 |
| Wskaźnik Szybkości | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-10M | $5M | $-39M | $-18M | $-29M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 29 emitentów · $3.8M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 10 (+6 vs poprzedni kw.) | 5 (-3 vs poprzedni kw.) | 9 (+4 vs poprzedni kw.) | 4 (+1 vs poprzedni kw.) | +733K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1 352 250 | 640 877 | 35,63% | Akcje |
| VANGUARD GROUP INC | $876 558 | 454 175 | 23,10% | Akcje |
| AMH Equity Ltd | $487 983 | 232 373 | 12,86% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $273 036 | 129 379 | 7,19% | Akcje |
| US BANCORP \DE\ | $255 141 | 120 920 | 6,72% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $192 578 | 91 269 | 5,07% | Akcje |
| STATE STREET CORP | $100 046 | 47 415 | 2,64% | Akcje |
| NORTHERN TRUST CORP | $72 181 | 34 209 | 1,90% | Akcje |
| TWO SIGMA ADVISERS, LP | $34 547 | 17 900 | 0,91% | Akcje |
| LPL Financial LLC | $31 416 | 14 889 | 0,83% | Akcje |
| StoneX Group Inc. | $24 745 | 11 153 | 0,65% | Akcje |
| Objectivity Squared, LLC | $23 031 | 10 915 | 0,61% | Akcje |
| Farther Finance Advisors, LLC | $19 940 | 9 450 | 0,53% | Akcje |
| UBS Group AG | $14 369 | 6 810 | 0,38% | Akcje |
| JANE STREET GROUP, LLC | $14 133 | 6 698 | 0,37% | Akcje |
| BlackRock, Inc. | $6 284 | 2 978 | 0,17% | Akcje |
| Vanguard Global Advisers, LLC | $6 203 | 2 940 | 0,16% | Akcje |
| Bay Harbor Wealth Management, LLC | $2 865 | 1 358 | 0,08% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $2 064 | 978 | 0,05% | Akcje |
| IFS Advisors, LLC | $2 004 | 950 | 0,05% | Akcje |
| SBI Securities Co., Ltd. | $1 361 | 645 | 0,04% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $828 | 396 | 0,02% | Akcje |
| Caitong International Asset Management Co., Ltd | $557 | 264 | 0,01% | Akcje |
| BARCLAYS PLC | $523 | 248 | 0,01% | Akcje |
| CALDWELL SUTTER CAPITAL, INC. | $211 | 100 | 0,01% | Akcje |
| MATHER GROUP, LLC. | $177 | 84 | 0,00% | Akcje |
| HRT FINANCIAL LP | $47 | 22 430 | 0,00% | Akcje |
| Virtu Financial LLC | $33 | 15 803 | 0,00% | Akcje |
| PRICE T ROWE ASSOCIATES INC /MD/ | $29 | 13 318 | 0,00% | Akcje |
Insiderzy spółki 30 insiderów · 13 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Christopherd T Guiffre | Chief Executive Officer | 6 stycznia 2017 A | 12 489 | 0 | 0 | $0 |
| Oliver Fetzer | President and CEO | 24 czerwca 2014 A | 30 000 | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Chief Financial Officer | 24 stycznia 2023 A | 443 512 | 0 | 0 | $0 |
| Gregg Beloff | CFO | 5 stycznia 2017 A | — | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Chef Executive Officer | 18 lutego 2026 A | 962 062 | 0 | 0 | $0 |
| Mardee Haring-Layton | Chief Accounting Officer | 4 września 2025 A | — | 0 | 0 | $0 |
| John A Fair | Chief Commercial Officer | 12 marca 2024 A | — | 0 | 0 | $0 |
| Scott Eliasof | SVP, Chief Scientific Officer | 5 stycznia 2017 A | — | 0 | 0 | $0 |
| Alejandra Carvajal | VP, General Counsel | 5 stycznia 2017 A | — | 0 | 0 | $0 |
| Adrian Senderowicz | SVP, Chief Medical Officer | 5 stycznia 2017 A | — | 0 | 0 | $0 |
| James E Oneill | Principal Accounting Officer | 5 stycznia 2017 A | 2 098 | 0 | 0 | $0 |
| Karen Lynn Roberts | Sr VP Finance & Administrat | 5 lutego 2015 A | — | 0 | 0 | $0 |
| Edward Graeme Garmey | Sr. VP, Chief Medical Officer | 5 lutego 2015 A | — | 0 | 0 | $0 |
| Jessica D. Grossman | Dyrektor | 30 czerwca 2026 A | 26 066 | 0 | 0 | $0 |
| Gregory W Matz | Dyrektor | 30 czerwca 2026 A | 30 847 | 0 | 0 | $0 |
| Susan L. Kelley | Dyrektor | 30 czerwca 2026 A | 23 696 | 0 | 0 | $0 |
| Robin Joan Steele | Dyrektor | 30 czerwca 2026 A | 47 055 | 0 | 0 | $0 |
| William H Rastetter | Dyrektor | 30 czerwca 2026 A | 39 721 | 0 | 0 | $0 |
| Sophia Nnenna Ononye-Onyia | Dyrektor | 21 czerwca 2023 A | — | 0 | 0 | $0 |
| Cheryl R Blanchard | Dyrektor | 21 czerwca 2023 A | — | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Dyrektor | 3 kwietnia 2017 A | 18 819 | 0 | 0 | $0 |
| Stuart A Arbuckle | Dyrektor | 3 stycznia 2017 A | 13 104 | 0 | 0 | $0 |
| David Ross Parkinson | Dyrektor | 3 stycznia 2017 A | 28 488 | 0 | 0 | $0 |
| William Mckee | Dyrektor | 3 stycznia 2017 A | 3 418 | 0 | 0 | $0 |
| David R Walt | Dyrektor | 3 stycznia 2017 A | 193 700 | 0 | 0 | $0 |
| Alan L Crane | Dyrektor | 22 czerwca 2016 A | 4 771 739 | 0 | 0 | $0 |
| Steven Edward Hall | Dyrektor | 26 czerwca 2015 A | 2 356 227 | 0 | 0 | $0 |
| CVF, LLC | Posiadacz 10% | 7 kwietnia 2015 P | 2 592 577 | 0 | 0 | $0 |
| Roger Hawley | — | 13 czerwca 2019 A | 944 956 | 0 | 0 | $0 |
| Rock Springs Capital Management LP | — | 15 kwietnia 2014 C | 464 365 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 8 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Roger L. Hawley, The Hawley Family Trust Dated October 22, 2004 ×4 zgłoszenia | 1 kwietnia 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Sabrina Martucci Johnson, Vincent S. Johnson and Sabrina M. Johnson Family Trust Dated February 14, 2005, Vincent S. Johnson ×3 zgłoszenia | 21 lutego 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Mark Walters, Walters Family Trust Dated January 15, 2009, Nancy Walters ×2 zgłoszenia | 16 kwietnia 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Lisa Walters-Hoffert, Lisa Walters-Hoffert Survivor’s Trust dated October 31, 2002 ×2 zgłoszenia | 15 kwietnia 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Polaris Venture Partners IV, L.P. (“PVP IV”), Polaris Venture Partners Entrepreneurs’ Fund IV, L.P. (“PVPE IV”), Polaris Venture Management Co. IV, L.L.C. (“PVM IV”), Jonathan A. Flint, Terrance G. McGuire ×2 zgłoszenia | 14 lutego 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Alan Crane ×2 zgłoszenia | 14 lutego 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 zgłoszenia | 14 lutego 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Daré Bioscience, Inc. | 28 marca 2017 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 3 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.